BellaSeno
BellaSeno’s Clinical Trial on 3D-Printed Breast Implants Shows Promising Early Results
Bioprinting firm BellaSeno has provided a public update on its ongoing clinical trial for resorbable breast scaffolding. The trial uses patients’ own fat with a 3D-printed scaffold, which gradually reabsorbs…
BellaSeno’s Pioneering 3D Printing Facility for Medical Implants to Open in 2025
German 3D printing medical implant pioneer BellaSeno plans to launch a fully automated production facility in Australia by mid-2025 to make its resorbable soft tissue and bone reconstruction implants. By…
BellaSeno Moves into Trauma Care with 3D Printed Patient-specific Bone Scaffold
BellaSeno, already exploring significant opportunities with its custom resorbable breast implants entering clinical trials, is expanding its scope. The company has received market approval for its bone scaffold product and…
3D Printing News Briefs, November 30, 2023: Material Database, Bone Scaffolds, & More
We’re starting off with lots of materials news in today’s 3D Printing News Briefs, from Replique, Asahi Kasei, and Arkema; plus, a team of researchers are 3D printing metals with…
BellaSeno Receives European Authorization for 3D Printed Bone and Chest Wall Implants
Founded in 2015, German medtech company BellaSeno GmbH develops novel resorbable 3D printed soft tissue and bone reconstruction implants, and last summer announced two clinical trials for its 3D printed…
3D Printed Breast & Chest Implants Enter Clinical Trials
Medtech company BellaSeno GmbH, headquartered in Leipzig, Germany, with its BellaSeno Pty subsidiary in Brisbane, Australia, specializes in the development of resorbable soft tissue and bone reconstruction implants, made with…
